Atossa Therapeutics
ATOS
#9237
Rank
C$0.14 B
Marketcap
C$1.10
Share price
5.24%
Change (1 day)
-36.02%
Change (1 year)

Atossa Therapeutics (ATOS) - Cash on Hand

Cash on Hand as of June 2025 : C$79.92 Million

According to Atossa Therapeutics's latest financial reports the company has C$79.92 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atossa Therapeutics - Cash on Hand chart (from 2010 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.10 B-13.06%
2023-12-31C$0.11 B-22.03%
2022-12-31C$0.15 B-13.42%
2021-12-31C$0.17 B244.62%
2020-12-31C$50.43 M206.93%
2019-12-31C$16.43 M16.2%
2018-12-31C$14.14 M55.83%
2017-12-31C$9.07 M123%
2016-12-31C$4.06 M-21.06%
2015-12-31C$5.15 M-47.75%
2014-12-31C$9.86 M46.12%
2013-12-31C$6.75 M293.53%
2012-12-31C$1.71 M-11.74%
2011-12-31C$1.94 M18864.84%
2010-12-31C$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$25.64 B 31,982.55%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$0.82 B 933.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$0.59 B 646.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$50.69 M-36.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$0.22 B 183.66%๐Ÿ‡บ๐Ÿ‡ธ USA